news
Teva and AbCellera team up to discover monoclonal antibodies
3 February 2016 | By Victoria White
AbCellera will apply its high-throughput single cell antibody platform for the discovery of the rare monoclonal antibodies...
List view / Grid view
Antibody Discovery
news
AbCellera and MSD enter antibody collaboration
28 January 2016 | By Victoria White
Under the agreement, AbCellera will apply its high-throughput antibody discovery platform to identify antibodies that specifically modulate target function...
news
Researchers isolate antibodies that neutralise multiple species of Ebola
22 January 2016 | By Victoria White
Researchers used a high-efficiency method they developed to quickly isolate and generate large quantities of monoclonal human antibodies from the blood of survivors of a 2007 outbreak in Uganda who were infected by the Bundibugyo Ebola virus...
news
F-star and AbbVie to develop bispecific antibodies in immuno-oncology
18 January 2016 | By Victoria White
Under the collaboration agreement, F-star and AbbVie will create Fcabs against two immuno-oncology targets and generate several mAb2 drug development candidates from these Fcabs...
news
An interview with Bernardo Perez-Ramirez, Sanofi, speaker at the 9th Annual Proteins & Antibodies Congress, 18-19 April 2016, London, UK
13 January 2016 | By Oxford Global
In anticipation of our Proteins and Antibodies Congress, Bernardo Perez-Ramirez spoke to us about his research and his expectations...
whitepaper
e-Book: Get the advantage with proven Ab discovery solutions
In this eBook you will learn how to shorten cell line development time and deliver stable clones with higher affinities and expression levels....
news
Ligand Pharmaceuticals to acquire OMT for $178 million
18 December 2015 | By Victoria White
OMT has leading antibody drug discovery technology and is believed to be the only company in the world offering three transgenic animal platforms for license...
news
BioAtla and Pfizer in CAB antibody collaboration
8 December 2015 | By Victoria White
BioAtla and Pfizer will each have a license to the other's respective technology to pursue the development and commercialisation of several CAB-ADC antibodies...
article
Protein Expression: The growing potential of plant-made monoclonal antibodies
The success story of Mapp Pharmaceuticals’ experimental drug, ZMapp, during last year’s Ebola outbreak highlights the potential of plant-made monoclonal antibodies (mAbs) as life-saving treatments.
news
XBiotech to develop antibody against C. Difficile
27 October 2015 | By Victoria White
Using its proprietary True Human technology, the Company has begun screening human blood samples from donors to identify and clone a therapeutic antibody candidate...
news
Scripps scientists make leukaemia cells kill each other
20 October 2015 | By Victoria White
The surprise finding could lead to a powerful new therapy for leukaemia and possibly other cancers...
news
Lilly and Innovent expand anti-PD-1 bispecific antibody collaboration
12 October 2015 | By Victoria White
As part of the expanded collaboration, Innovent could receive additional milestones totalling more than $1 billion if the products reach certain milestones...
news
New company LA Cell to focus on cell-penetrating antibody therapies
29 September 2015 | By Victoria White
LA Cell has exclusively licensed technology that enables modified monoclonal antibodies to penetrate into cells and target "undruggable" disease-causing molecules...
news
Regeneron and ETI team up to discover monoclonal antibodies
24 September 2015 | By Victoria White
Regeneron will provide the ETI with access to VelocImmune technology to generate antibodies against targets of interest and explore potential therapeutic applications for human disease...
news
MorphoSys and Immatics enter immuno-oncology alliance
25 August 2015 | By Victoria White
MorphoSys and Immatics have formed an alliance to generate antibody-based therapeutics against multiple proprietary cancer antigens recognised by T cells...
